Accessibility Menu
Winston Pharmaceuticals logo

Winston Pharmaceuticals

(OTC) WPHM

Current Price$0.00
Market Cap$7,700
Since IPO (2008)-100%
5 Year-100%
1 Year+9,900%
1 Month+0%

Winston Pharmaceuticals Financials at a Glance

Market Cap

$7,700

Revenue (TTM)

$1.37M

Net Income (TTM)

$2.34M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

3318.84 (High)

Price

$0.00

Volume

400

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

WPHM News

No articles available.

WPHM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Winston Pharmaceuticals

Industry

Pharmaceuticals

Headquarters

Vernon Hills, US

WPHM Financials

Key Financial Metrics (TTM)

Gross Margin

99%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

0%

Return on Capital

-6%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.70K

Shares Outstanding

77.41M

Volume

400

Short Interest

0.00%

Avg. Volume

6.667

Financials (TTM)

Gross Profit

$1.39M

Operating Income

$2.74M

EBITDA

$2.73M

Operating Cash Flow

$4.20M

Capital Expenditure

$1.01K

Free Cash Flow

$4.20M

Cash & ST Invst.

$1.56M

Total Debt

$0.00

Winston Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2010YOY CHG

Revenue

$316.71K

-6.8%

Gross Profit

$316.71K

-6.8%

Gross Margin

100.00%

N/A

Market Cap

$7.70K

N/A

Market Cap/Employee

$855.56

N/A

Employees

9

N/A

Net Income

$460.69K

+40.8%

EBITDA

$459.40K

+41.6%

Quarterly Fundamentals

Name
Q1 2010YOY CHG

Net Cash

$677.52K

-83.8%

Accounts Receivable

$0.00

-100.0%

Inventory

$28.93K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.58%

N/A

Return on Invested Capital

-5.61%

N/A

Free Cash Flow

$885.33K

+42.5%

Operating Cash Flow

$883.43K

+42.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BTAXBiostax Corp.
$0.00+0.00%
TCLIFTheraclion S.A.
$0.00+0.00%
SESISES Solar Inc.
$0.00+0.00%
KKURChromoCure, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.58+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.54-0.03%
TLTiShares Trust - iShares 20+ Year Treasury Bond ETF
$86.05-0.02%
PLPlanet Labs PBC
$33.91+0.26%

Questions About WPHM

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.